Catalyst Wire Dossier Catalyst Wire Dossier

CEVIMELINE

cevimeline hydrochloride · Bionpharma Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CEVIMELINE, covering 2014-05-22 to 2023-11-08. Get the full timeline:

Most recent: FDA Approved: CEVIMELINE — Original Application (Bionpharma Inc)

See pricing